International Hepatology

Cirrhotic patients with clinically significant portal hypertension (CSPH) often develop refractory ascites. Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established treatment for CSPH, but it carries a substantial risk of…

Editorial Note: Metabolic-associated steatohepatitis (MASH) is a subtype of metabolic-associated fatty liver disease (MASLD), characterized by hepatic steatosis, lobular inflammation, and hepatocellular ballooning, with a high risk of progressing to…

From February 20 to 22, 2025, the European Association for the Study of the Liver (EASL) hosted the Liver Cancer Summit in Paris, France. During this prestigious academic event, our…

Editorial Note: Hepatitis B virus (HBV) infection is a global public health challenge, causing nearly a million deaths annually due to complications such as liver failure, cirrhosis, and hepatocellular carcinoma.…

Editorial Note: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 32% of the global population. Without proper intervention, it can progress to metabolic dysfunction-associated steatohepatitis (MASH), liver fibrosis, cirrhosis, and…

A research team led by Dr. Dong Zhang and Dr. Guangyong Sun from Beijing Chaoyang Hospital, Capital Medical University, in collaboration with Dr. Zhongtao Zhang from Beijing Friendship Hospital, Capital…

Today, we join the global community in recognizing World Hepatitis Day. This year’s theme, "Eliminate Hepatitis · Take Action Positively," underscores the importance of proactive measures in combating this liver…

Introduction: Interventional therapy is an emerging clinical discipline and a key component of minimally invasive medicine. It stands as an independent field alongside traditional internal medicine and surgery, forming the…

Autoimmune hepatitis (AIH) presents ongoing challenges in diagnosis and treatment, requiring continuous research to improve patient outcomes. Professor Michael A. Heneghan has been a leading voice in AIH research, providing…

Editor's Note: China has a high incidence of liver cancer, with most patients being diagnosed at an advanced stage, losing the opportunity for surgical cure. Currently, the treatment for advanced…